tm logo
REZIPRES
Live/Registered
REGISTERED

on 02 May 2023

Last Applicant/ Owned by

Elisabethenanlage 11

Basel

CH

4051

Serial Number

90060774 filed on 19th Jul 2020

Registration Number

7043502 registered on 02th May 2023

in the Principal Register

Correspondent Address

Basel, 4051

Switzerland

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

REZIPRES

Pharmaceutical preparations for treatment of hypotension; pharmaceutical compositions for treatment of hypotension; pharmaceutical formulations for treatment of hypotension in the setting of anesthesia; pharmaceutical formulations containing ephedrine for treatment of clinically important hypotension in the setting of anesthesia; pharmaceutical formulations for treatment of hypotension

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for treatment of hypotension; pharmaceutical compositions for treatment of hypotension; pharmaceutical formulations for treatment of hypotension in the setting of anesthesia; pharmaceutical formulations containing ephedrine for treatment of clinically important hypotension in the setting of anesthesia; pharmaceutical formulations for treatment of hypotension


First Use Date in General

14th Mar 2022

First Use Date in Commerce

14th Mar 2022

Mark Details


Serial Number

No 90060774

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
04th Jun 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED
04th Jun 2024WITHDRAWAL OF ATTORNEY GRANTED
02th May 2023REGISTERED-PRINCIPAL REGISTER
02th May 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
31st Mar 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
30th Mar 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
15th Mar 2023TEAS/EMAIL CORRESPONDENCE ENTERED
15th Mar 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
15th Mar 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
29th Sep 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED